Effects of KP-496, a Novel Dual Antagonist for Cysteinyl Leukotriene Receptor 1 and Thromboxane A2 Receptor, on Sephadex-Induced Airway Inflammation in Rats-Reference-Cited by-同舟云学术

Effects of KP-496, a Novel Dual Antagonist for Cysteinyl Leukotriene Receptor 1 and Thromboxane A2 Receptor, on Sephadex-Induced Airway Inflammation in Rats

Published:2009 Issue:6 Volume:32 Page:1057-1061
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Ishimura Masakazu¹,Maeda Takashi¹,Kataoka Sayuri¹,Suda Masahiro¹,Kurokawa Shigeo¹,Hiyama Yoshiyuki²

Affiliation:

1. Pharmacology Department, Central Research Laboratories, Kaken Pharmaceutical Co., Ltd.

2. Pharmacokinetics and Safety Research Department, Central Research Laboratories, Kaken Pharmaceutical Co., Ltd.

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

http://www.jstage.jst.go.jp/article/bpb/32/6/32_6_1057/_pdf

Reference48 articles.

1. Leukotrienes are potent constrictors of human bronchi

2. Pharmacology of montelukast sodium (Singulair™), a potent and selective leukotriene D4 receptor antagonist

3. The Preclinical Pharmacology of ICI 204,219: A Peptide Leukotriene Antagonist

4. Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JTE-852, a novel spleen tyrosine kinase inhibitor, blocks antigen-induced allergic reactions in rats;Journal of Veterinary Medical Science;2018

2. JTE-852, a novel spleen tyrosine kinase inhibitor, blocks immunoglobulin G-mediated cellular responses and autoimmune reactions in vivo;Life Sciences;2017-12

3. The influence of leukotrienes C4 and D4 on the contractility of an inflamed porcine uterus;Theriogenology;2015-05

4. Two-start design within a Sephadex inflammatory model – A means to generate reliable ED50 data whilst significantly reducing the number of animals used;Pulmonary Pharmacology & Therapeutics;2012-06

5. Thromboxane A2Receptor;Journal of Cardiovascular Pharmacology and Therapeutics;2011-11-07